ZA959073B - Process for preparing solid pharmaceutical dosage forms - Google Patents

Process for preparing solid pharmaceutical dosage forms

Info

Publication number
ZA959073B
ZA959073B ZA959073A ZA959073A ZA959073B ZA 959073 B ZA959073 B ZA 959073B ZA 959073 A ZA959073 A ZA 959073A ZA 959073 A ZA959073 A ZA 959073A ZA 959073 B ZA959073 B ZA 959073B
Authority
ZA
South Africa
Prior art keywords
water
active substance
pharmaceutically active
dosage forms
pharmaceutical dosage
Prior art date
Application number
ZA959073A
Other languages
English (en)
Inventor
Richard John Yarwood
Patrick Kearney
Andrew Roy Thompson
Original Assignee
Scherer Corp R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Corp R P filed Critical Scherer Corp R P
Publication of ZA959073B publication Critical patent/ZA959073B/xx

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D25/00—Filters formed by clamping together several filtering elements or parts of such elements
    • B01D25/12—Filter presses, i.e. of the plate or plate and frame type
    • B01D25/176—Filter presses, i.e. of the plate or plate and frame type attaching the filter element to the filter press plates, e.g. around the central feed hole in the plates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA959073A 1994-10-28 1995-10-26 Process for preparing solid pharmaceutical dosage forms ZA959073B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9421837A GB9421837D0 (en) 1994-10-28 1994-10-28 Process for preparing solid pharmaceutical dosage forms
CA002134611A CA2134611C (fr) 1994-10-28 1994-10-28 Procede de preparation de formes posologiques solides
US08/330,936 US5738875A (en) 1994-10-28 1994-10-28 Process for preparing solid pharmaceutical dosage forms

Publications (1)

Publication Number Publication Date
ZA959073B true ZA959073B (en) 1996-05-22

Family

ID=27169885

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959073A ZA959073B (en) 1994-10-28 1995-10-26 Process for preparing solid pharmaceutical dosage forms

Country Status (16)

Country Link
US (1) US5738875A (fr)
EP (1) EP0737065B1 (fr)
JP (2) JP3839845B2 (fr)
CN (1) CN1204877C (fr)
AT (1) ATE198150T1 (fr)
AU (1) AU3702895A (fr)
CA (1) CA2134611C (fr)
DE (1) DE69519664T2 (fr)
DK (1) DK0737065T3 (fr)
ES (1) ES2153498T3 (fr)
GB (1) GB9421837D0 (fr)
GR (1) GR3035194T3 (fr)
MX (1) MX9602514A (fr)
PT (1) PT737065E (fr)
WO (1) WO1996013252A1 (fr)
ZA (1) ZA959073B (fr)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5738875A (en) * 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
US8071128B2 (en) * 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
GB9702799D0 (en) * 1997-02-12 1997-04-02 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
US5976577A (en) * 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
BR0007360A (pt) * 1999-12-23 2001-08-14 Johnson & Johnson Composição de liberação controlada
WO2001064202A2 (fr) * 2000-03-01 2001-09-07 Euro-Celtique S.A. Traitement de troubles gastro-intestinaux fonctionnels
US6814978B2 (en) 2000-12-29 2004-11-09 Mcneil-Ppc, Inc. Process for preparing a soft tablet
WO2002100381A1 (fr) * 2001-06-07 2002-12-19 Tanabe Seiyaku Co., Ltd. Preparations a base de grains fonctionnels se desintegrant rapidement dans la cavite buccale
PL368612A1 (en) * 2001-08-14 2005-04-04 Biotie Therapies Corporation Method of treating alcoholism or alcohol abuse
JP2005519865A (ja) * 2001-09-25 2005-07-07 ランバクシー ラボラトリーズ リミテッド 急速溶解性投薬形態物の製造方法
CA2447984A1 (fr) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Formes dosifiees presentant un noyau interne et une couche externe de formes differentes
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
EP1485296B1 (fr) * 2002-02-13 2011-07-20 Michael K. Weibel Forme posologique medicamenteuse et procede de fabrication
WO2003077842A2 (fr) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Suspension orale de gout agreable et procede associe
US20040001885A1 (en) * 2002-06-27 2004-01-01 Unchalee Kositprapa Rapidly disintegrating antihistamine formulation
US7985422B2 (en) * 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040234579A1 (en) * 2003-05-22 2004-11-25 Mark D. Finke, Inc. Dietary supplements and methods of preparing and administering dietary supplements
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
EP1670441A4 (fr) * 2003-10-07 2012-05-02 Andrx Pharmaceuticals Llc Formulation a desintegration rapide
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
CA2866501A1 (fr) 2003-11-10 2005-05-26 Allergan, Inc. Compositions pharmaceutiques comportant de la desmopressine faiblement dosee
EP1582221A1 (fr) 2004-03-31 2005-10-05 Chiesi S.A. Composition pharmaceutique pour masquer le gout de principes actifs
US8545881B2 (en) 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) * 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
AU2005299490C1 (en) 2004-10-21 2012-01-19 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
ITMI20042356A1 (it) * 2004-12-10 2005-03-10 Acraf Composizione farmaceutica orodisperdibile e procedimento per prepararla
US8697674B2 (en) * 2004-12-29 2014-04-15 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US20070293580A1 (en) * 2006-06-05 2007-12-20 Malcolm Hill Methods for Buccal, Lingual or Sublingual Dosing Regimens of Epinephrine for the Treatment of Allergic Emergencies
TW200817049A (en) * 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
US8545879B2 (en) 2009-08-31 2013-10-01 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam
KR101765357B1 (ko) 2009-12-02 2017-08-04 아데어 파마수티컬스 에스.알.엘. 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물
AR079862A1 (es) * 2010-01-08 2012-02-22 Eurand Inc Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion
US10548839B2 (en) * 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
MX365568B (es) 2010-12-02 2019-06-07 Adare Pharmaceuticals Inc Granulos de dispersion rapida, comprimidos de disolucion oral y metodos.
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
CA2906107C (fr) 2013-03-15 2021-08-24 Aprecia Pharmaceuticals Company Forme posologique d'oxcarbazepine a dispersion rapide
AU2014228990B2 (en) 2013-03-15 2017-02-02 Aprecia Pharmaceuticals LLC Rapid disperse dosage form containing levetiracetam
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
WO2014144661A1 (fr) 2013-03-15 2014-09-18 Aprecia Pharmaceuticals Compny Forme posologique à dispersion rapide de topiramate
US9789066B2 (en) 2014-01-10 2017-10-17 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CA3018828C (fr) 2014-09-17 2021-05-11 Steerlife India Private Limited Composition effervescente et son procede de fabrication
WO2017098481A1 (fr) 2015-12-12 2017-06-15 Steerlife India Private Limited Compositions effervescentes de metformine et leurs procédés de préparation
WO2017168174A1 (fr) 2016-04-02 2017-10-05 N4 Pharma Uk Limited Nouvelles formes pharmaceutiques du sildénafil
WO2018002673A1 (fr) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Nouvelles formulations d'antagonistes du récepteur de l'angiotensine ii
IT201600078683A1 (it) * 2016-07-27 2018-01-27 Mattia Saporiti Matrice edibile per uso veterinario e zootecnico e relativo metodo di produzione
WO2018115888A1 (fr) 2016-12-21 2018-06-28 N4 Pharma Uk Limited Nouvelles formulations d'aprépitant
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
WO2020104837A1 (fr) 2018-11-21 2020-05-28 Rosemont Pharmaceuticals Limited Formulations de suspension de topiramate orale présentant une stabilité de conservation prolongée et une biodisponibilité améliorée
GB2585413B (en) 2019-02-22 2023-04-26 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
CN113507923B (zh) * 2019-02-22 2024-03-26 康特伦英国斯温顿捷迪斯有限公司 在线混合期间混悬液的曝气最小化
WO2020169989A1 (fr) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Réduction au minimum de l'agglomération, de l'aération et préservation du revêtement de compositions pharmaceutiques comprenant de l'ibuprofène
TWI849062B (zh) 2019-02-22 2024-07-21 英商康泰倫特英國斯文敦載迪斯有限公司 保存水性懸浮液中以無溶劑混合方法製備的功能性塗覆之活性醫藥成份微粒
AU2021296908A1 (en) 2020-06-26 2023-02-16 Aprecia Pharmaceuticals LLC Rapidly-orodispersible tablets having an interior cavity
BR112023001716A2 (pt) 2020-07-31 2023-04-04 Catalent Uk Swindon Zydis Ltd Composições farmacêuticas compreendendo api revestido
WO2022179634A1 (fr) * 2021-02-27 2022-09-01 北京兴源联合医药科技有限公司 Préparation orale lyophilisée
JP2024516827A (ja) 2021-04-30 2024-04-17 マインド メディシン， インコーポレイテッド Ｌｓｄ塩結晶形態
AU2022331315B2 (en) 2021-08-19 2025-10-16 Definium Therapeutics US, Inc. Lyophilized orally disintegrating tablet formulations of d-lysergic acid diethylamide for therapeutic applications
WO2025217640A1 (fr) 2024-04-12 2025-10-16 Eli Lilly And Company Compositions et méthodes de traitement de maladies métaboliques

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (fr) * 1977-07-20 1981-03-10 George K. E. Gregory Emballages
IE53696B1 (en) * 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
GB2111423B (en) * 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5039540A (en) * 1989-08-14 1991-08-13 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
EP0578823B1 (fr) * 1991-04-08 2002-01-23 Sumitomo Pharmaceuticals Company, Limited Preparation solide poreuse contenant une substance proteique physiologiquement active
ATE172637T1 (de) * 1991-12-24 1998-11-15 Yamanouchi Pharma Co Ltd Intrabukkal desintegrierende zubereitung und ihre herstellung
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
JPH06298668A (ja) * 1993-02-18 1994-10-25 Takeda Chem Ind Ltd 経口用医薬組成物
US5382437A (en) * 1993-10-25 1995-01-17 Hunter Research Corporation Frozen liquified gas composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5738875A (en) * 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms

Also Published As

Publication number Publication date
JP2006111635A (ja) 2006-04-27
ATE198150T1 (de) 2001-01-15
ES2153498T3 (es) 2001-03-01
DE69519664D1 (de) 2001-01-25
WO1996013252A1 (fr) 1996-05-09
JP3839845B2 (ja) 2006-11-01
CA2134611C (fr) 2002-12-24
CN1140407A (zh) 1997-01-15
CA2134611A1 (fr) 1996-04-29
JPH09511256A (ja) 1997-11-11
US5738875A (en) 1998-04-14
CN1204877C (zh) 2005-06-08
AU3702895A (en) 1996-05-23
DE69519664T2 (de) 2001-05-17
GR3035194T3 (en) 2001-04-30
PT737065E (pt) 2001-04-30
MX9602514A (es) 1997-05-31
GB9421837D0 (en) 1994-12-14
EP0737065A1 (fr) 1996-10-16
DK0737065T3 (da) 2001-01-15
EP0737065B1 (fr) 2000-12-20

Similar Documents

Publication Publication Date Title
GB9421837D0 (en) Process for preparing solid pharmaceutical dosage forms
MX9602515A (es) Procedimiento para preparar formas de dosis farmaceuticas de substancias hidrofobicas.
GB9702799D0 (en) Process for preparing solid pharmaceutical dosage forms
HK1038709A1 (zh) 製備結晶顆粒的設備和方法
AU1729397A (en) Process to prepare soluble delivery systems using volatile salts
IL141532A0 (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
CA2193337A1 (fr) Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs
AU3533395A (en) Oral sustained-release preparation
HUP0001464A3 (en) Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
CA2256751A1 (fr) Comprime enrobe a base de maleate de trimebutine
EP0764019A4 (fr) Procede et appareil pour fabriquer des unites de prise a dissolution rapide, et produit ainsi obtenu
MXPA02009797A (es) Preparaciones farmaceuticas y su manufactura.
SG117292G (en) (s)-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride monohydrate,process for its preparation and pharmaceutical preparation containing it
CA2326840A1 (fr) Medicaments galeniques a base de carvedilol
CS265391A3 (en) Novel thienodiazepines, process for their preparation and pharmaceutical comprising them
HUT49873A (en) Herbicides and acaricides, as well as process for producing the active ingredient aryl- or heteroaryldione derivatives
HUP9601323A3 (en) 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics pharmaceutical compns. contg. them and process for preparing the said compds. and use of the compds.
HUT72305A (en) Hydroxamic acid derivatives, pharmaceutical compns. conta. them, process for preparing the said compds. and use of them
HU901352D0 (en) Process for producing of pharmaceutical compositions comprising vegetable active ingredients, suitable for treatment of asthma
SI0981332T1 (en) Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
HUP9700650A2 (hu) Gyógyhatású készítmények és eljárás a hatóanyag előállítására